Fengyan Yuan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Endoplasmic Reticulum

Chemotherapy Induced

Hydrogen Peroxide

Top Venues

Cancer gene therapy

Oxidative medicine and cellular longevity

This page only lists publications with an associated author ORCID identifier.

Publications

Fengyan Yuan, Huiqin Zhou, Chongyang Liu, Yi Wang, Jing Quan, Jie Liu, Hao Li, Mark von Itzstein, Xing Yu
Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2α pathway. Cancer gene therapy 31 (6) (2024)
Fengyan Yuan, Huiqin Zhou, Chongyang Liu, Yi Wang, Jing Quan, Jie Liu, Hao Li, Mark von Itzstein, Xing Yu
Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2α pathway. Cancer gene therapy (2024)
Fengyan Yuan, Huiqin Zhou, Chongyang Liu, Yi Wang, Jing Quan, Jie Liu, Hao Li, Mark von Itzstein, Xing Yu
Heparanase interacting BCLAF1 to promote the development and drug resistance of ICC through the PERK/eIF2α pathway. Cancer gene therapy 31 (6) (2024)
Yujing Zhang, Gang Yang, Shuai Huang, Xinyue Yang, Fengyan Yuan, Yinghui Song, Sulai Liu, Xing Yu
Regulation of Cr(VI)-Induced Premature Senescence in L02 Hepatocytes by ROS-Ca 2+ -NF- κ B Signaling. Oxidative medicine and cellular longevity 2022 (2022)